JavaScript is NOT enabled !

Please enable JavaScript.

Article

FT
PubMed

This record comes from PubMed

Corrigendum: Clinical efficacy, safety and tolerability of a new subcutaneous immunoglobulin 16.5% (Octanorm [Cutaquig®]) in the treatment of patients with primary immunodeficiencies

Kobayashi, Roger H
Author Kobayashi, Roger H UCLA School of Medicine, Los Angeles, CA, United States
Gupta, Sudhir
Author Gupta, Sudhir Division of Basic and Clinical Immunology, University of California, Irvine, Irvine, CA, United States
Melamed, Isaac
Author Melamed, Isaac IMMUNOe Research Center, Centennial, CO, United States
Mandujano, J Fernando
Author Mandujano, J Fernando Pediatric Pulmonary Associates of North Texas, Frisco, TX, United States
Kobayashi, Ai Lan
Author Kobayashi, Ai Lan Midlands Pediatrics, Papillion, NE, United States
Ritchie, Bruce
Author Ritchie, Bruce Divisionof Hematology, Department of Medicine, University of Alberta Hospital, Edmonton, AB, Canada
Geng, Bob
Author Geng, Bob Divisions of Adult and Pediatric Allergy and Immunology, University of California, San Diego, La Jolla, CA, United States
Atkinson, Thomas Prescott
Author Atkinson, Thomas Prescott Department of Pediatric Allergy, Asthma and Immunology, University of Alabama, Birmingham, AL, United States
Rehman, Syed
Author Rehman, Syed Allergy and Asthma Center Inc., Toledo, OH, United States
Turpel-Kantor, Eva
Author Turpel-Kantor, Eva Octapharma Pharmazeutika Produktionsges.m.b.H., Vienna, Austria
Litzman, Jiří
Author Litzman, Jiří Department of Clinical Immunology and Allergology, St Anne's University Hospital in Brno, Faculty of Medicine, Masaryk University, Brno, Czechia

Frontiers in immunology. 2022 ; 13 () : 1110388. [epub] 20221220

Front Immunol
ISSN 1664-3224
Source

Status PubMed-not-MEDLINE Language English Country Switzerland Media electronic-ecollection

Document type Published Erratum

Persistent link https://www.medvik.cz/link/pmid36605207

Online Full text

PubMed 36605207
PubMed Central PMC9809273
DOI 10.3389/fimmu.2022.1110388
Knihovny.cz E-resources

Keywords
SCIG, antibodies, immunoglobulins, infections, infusion site reactions, primary immunodeficiencies,
Publication type
Published Erratum MeSH

[This corrects the article DOI: 10.3389/fimmu.2019.00040.].

Allergy and Asthma Center Inc Toledo OH United States

Department of Clinical Immunology and Allergology St Anne's University Hospital in Brno Faculty of Medicine Masaryk University Brno Czechia

Department of Pediatric Allergy Asthma and Immunology University of Alabama Birmingham AL United States

Division of Basic and Clinical Immunology University of California Irvine Irvine CA United States

Divisionof Hematology Department of Medicine University of Alberta Hospital Edmonton AB Canada

Divisions of Adult and Pediatric Allergy and Immunology University of California San Diego La Jolla CA United States

IMMUNOe Research Center Centennial CO United States

Midlands Pediatrics Papillion NE United States

Octapharma Pharmazeutika Produktionsges m b H Vienna Austria

Pediatric Pulmonary Associates of North Texas Frisco TX United States

UCLA School of Medicine Los Angeles CA United States

Erratum For

Front Immunol. 2019 Feb 04;10:40. doi: 10.3389/fimmu.2019.00040. PubMed

References provided by Crossref.org

Borrow
RIS

Find record

In BMC

Citation metrics